HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
G De Palo Selected Research
G De Palo Research Topics
Disease
8
Neoplasms (Cancer)
07/2006 - 01/2000
7
Breast Neoplasms (Breast Cancer)
07/2006 - 01/2000
2
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2004 - 01/2002
2
Carcinoma (Carcinomatosis)
01/2004 - 12/2001
2
Carcinogenesis
12/2001 - 01/2001
1
Carcinoma in Situ
01/2004
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2002
1
Testicular Neoplasms (Testicular Cancer)
12/2001
1
Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2001
1
Ovarian Epithelial Carcinoma
12/2001
1
Granulosa Cell Tumor
12/2001
1
Dysgerminoma
12/2001
1
Colorectal Neoplasms (Colorectal Cancer)
01/2000
Drug/Important Bio-Agent (IBA)
5
Fenretinide
IBA
07/2006 - 01/2001
4
Retinoids
IBA
07/2006 - 01/2001
3
Insulin-Like Peptides
IBA
10/2001 - 01/2000
2
Insulin-Like Growth Factor I (IGF-1)
IBA
10/2001 - 01/2000
2
Tamoxifen
FDA Link
Generic
01/2001 - 01/2000
2
Biomarkers (Surrogate Marker)
IBA
01/2000 - 01/2000
1
Radium
IBA
01/2004
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2002
1
Inhibins (Inhibin)
IBA
12/2001
1
Tumor Biomarkers (Tumor Markers)
IBA
12/2001
1
Activins (Activin)
IBA
12/2001
1
Tretinoin (Retinoic Acid)
FDA Link
Generic
10/2001
1
Raloxifene Hydrochloride (Evista)
FDA Link
01/2001
1
Selective Estrogen Receptor Modulators (SERM)
IBA
01/2001
1
Vitamin A (Retinol)
FDA Link
Generic
02/2000
1
Proteins (Proteins, Gene)
FDA Link
01/2000
1
Mitogens
IBA
01/2000
Therapy/Procedure
2
Therapeutics
01/2004 - 01/2000
2
Radiotherapy
01/2002 - 01/2000
2
Chemoprevention
01/2001 - 01/2000
1
Aftercare (After-Treatment)
07/2006
1
Drug Therapy (Chemotherapy)
01/2004
1
Secondary Prevention
01/2001
1
Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2000